Release of reactive oxygen species and DAMPs such as high mobility group box 1 (HMGB1) further amplify inflammatory cytokine production via TLR signaling thereby positioning ECs as both a target and contributor of the “cytokine storm” that perpetuates GVHD (40–42). Here, HMGB1 is linked to graft versus host disease.